Medium materiality6/10
Cinemark Holdings (CNK) Reiterated at Buy by Benchmark as Q2 Estimates Raised
Why it may matterVerify against the original reporting
Buy reaffirmation
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CNK target $37; current price $31.57; Guggenheim notes Q2 estimates raised; Benchmark reiterates Buy.
- Target $37; Price $31.57; Analyst: Guggenheim; Benchmark reiterates Buy
Key facts
- 01
Target: $37
- 02
Posted price: $31.57
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.